European genomics company GenePlanet has secured a strategic investment from healthcare-focused private equity firm Lauxera Capital Partners, marking the next phase of the company’s international expansion. At the same time, existing investor BlackPeak Capital has partially exited its position after three years of backing the company, while retaining a significant stake for the journey ahead.